2WW0

GOL: GLYCEROL

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
2WW0_GOL_E_802	60%	69%	0.162	0.949	0.36	0.82	-	-	0	0	100%	1
2WW0_GOL_F_802	57%	80%	0.179	0.954	0.38	0.45	-	-	0	0	100%	1
2WW0_GOL_B_803	56%	75%	0.181	0.953	0.43	0.55	-	-	2	0	100%	1
2WW0_GOL_A_805	51%	75%	0.186	0.94	0.34	0.62	-	-	0	0	100%	1
2WW0_GOL_A_803	46%	56%	0.214	0.949	0.45	1.24	-	-	2	0	100%	1
2WW0_GOL_A_806	44%	86%	0.18	0.906	0.42	0.31	-	-	0	0	100%	1
2WW0_GOL_A_802	38%	92%	0.239	0.941	0.35	0.18	-	-	0	0	100%	1
2WW0_GOL_B_804	37%	60%	0.189	0.885	0.47	1.04	-	-	4	0	100%	1
2WW0_GOL_E_803	31%	81%	0.214	0.884	0.4	0.41	-	-	0	0	100%	1
2WW0_GOL_D_803	29%	66%	0.291	0.95	0.4	0.89	-	-	0	0	100%	1
2WW0_GOL_B_802	25%	73%	0.29	0.926	0.37	0.67	-	-	0	0	100%	1
2WW0_GOL_A_804	23%	52%	0.251	0.874	0.56	1.28	-	1	1	0	100%	1
2WW0_GOL_D_804	19%	76%	0.298	0.894	0.4	0.54	-	-	3	0	100%	1
2WW0_GOL_D_802	18%	89%	0.335	0.924	0.4	0.23	-	-	2	0	100%	1
2WW0_GOL_C_803	13%	73%	0.271	0.808	0.47	0.57	-	-	6	0	100%	1
2WW0_GOL_C_804	9%	59%	0.337	0.835	0.41	1.14	-	1	0	0	100%	1
2WW0_GOL_C_802	3%	89%	0.337	0.661	0.42	0.24	-	-	0	0	100%	1
2WVX_GOL_A_802	94%	82%	0.076	0.974	0.36	0.44	-	-	0	0	100%	1
2YOQ_GOL_A_1196	100%	35%	0.024	0.996	0.38	2.12	-	2	0	0	100%	1
4KFD_GOL_D_806	100%	57%	0.024	0.995	0.41	1.21	-	-	0	0	100%	1
4KFE_GOL_E_803	100%	63%	0.024	0.995	0.31	1.07	-	-	0	0	100%	1
1M5Q_GOL_W_4006	100%	0%	0.027	0.992	4.89	6.2	5	3	0	0	100%	1
2Y3G_GOL_A_1150	100%	85%	0.029	0.995	0.36	0.39	-	-	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.